Todd Bazemore, Chief Operating Officer at Kala Pharmaceuticals, Inc. (KALA), bought 81,042 shares at $13.39 ($331) on 2020-06-05, disclosed to the SEC on 2020-10-28.
Open-market purchase of $331 KALA by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.39 | 2 | $27 | 8.1% |
| 2 | $7.60 | 40 | $304 | 91.9% |
| 3 | $0.00 | 81,000 | $0 | 0.0% |
| Total | $0.00 avg | 81,042 | $331 | 100% |
| Filing → |
| KALA | SELL | 2025-06-04 | $13K | — | Filing → |
| KALA | SELL | 2025-01-07 | $15K | — | Filing → |
| KALA | SELL | 2024-06-27 | $22K | — | Filing → |